22,23-dihydrobrassicasterol

22,23-dihydrobrassicasterol is a lipid of Sterol Lipids (ST) class. 22,23-dihydrobrassicasterol is associated with abnormalities such as Diabetes, Macular degeneration, Drusen, Systemic disease and Diabetes Mellitus. The involved functions are known as cholesterol metabolism, Synthesis, Intestinal Absorption, Liver function and cholesterol absorption. 22,23-dihydrobrassicasterol often locates in Back and Cell membrane. The associated genes with 22,23-dihydrobrassicasterol are apolipoprotein E-3. The related lipids are Total cholesterol, campesterol, lathosterol, Fatty Acids, Nonesterified and Cholesterol, Dietary.

Cross Reference

Introduction

To understand associated biological information of 22,23-dihydrobrassicasterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 22,23-dihydrobrassicasterol?

22,23-dihydrobrassicasterol is suspected in Diabetes, Macular degeneration, Drusen, Systemic disease, Diabetes Mellitus, Liver diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 22,23-dihydrobrassicasterol

MeSH term MeSH ID Detail
Hypolipoproteinemias D007009 9 associated lipids
Xanthomatosis D014973 17 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Coronary Disease D003327 70 associated lipids
Hyperlipidemias D006949 73 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Total 7

PubChem Associated disorders and diseases

What pathways are associated with 22,23-dihydrobrassicasterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 22,23-dihydrobrassicasterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 22,23-dihydrobrassicasterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 22,23-dihydrobrassicasterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 22,23-dihydrobrassicasterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 22,23-dihydrobrassicasterol?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 22,23-dihydrobrassicasterol

Download all related citations
Per page 10 20 50 100 | Total 313
Authors Title Published Journal PubMed Link
Moreno-Anzúrez NE et al. A Cytotoxic and Anti-inflammatory Campesterol Derivative from Genetically Transformed Hairy Roots of Lopezia racemosa Cav. (Onagraceae). 2017 Molecules pmid:28085103
Salinas R et al. Production of the anti-inflammatory compound 6-O-palmitoyl-3-O-β-D-glucopyranosylcampesterol by Callus cultures of Lopezia racemosa Cav. (Onagraceae). 2014 Molecules pmid:24962399
Malek SN et al. Cytotoxic components of Pereskia bleo (Kunth) DC. (Cactaceae) leaves. 2009 Molecules pmid:19471192
Morrison AH and Ritter KS Effect of host insect sterols on the development and sterol composition of Steinernema feltiae. 1986 Mol. Biochem. Parasitol. pmid:3724794
Labonté MÈ et al. Comparison of the impact of trans fatty acids from ruminant and industrial sources on surrogate markers of cholesterol homeostasis in healthy men. 2011 Mol Nutr Food Res pmid:21656668
Aherne SA and O'Brien NM Modulation of cytokine production by plant sterols in stimulated human Jurkat T cells. 2008 Mol Nutr Food Res pmid:18465778
Plat J et al. Preferential campesterol incorporation into various tissues in apolipoprotein E*3-Leiden mice consuming plant sterols or stanols. 2008 Metab. Clin. Exp. pmid:18702950
Kempen HJ et al. Lathosterol level in plasma is elevated in type III hyperlipoproteinemia, but not in non-type III subjects with apolipoprotein E2/2 phenotype, nor in type IIa or IIb hyperlipoproteinemia. 1991 Metab. Clin. Exp. pmid:2000034
Sudhop T et al. Serum plant sterols as a potential risk factor for coronary heart disease. 2002 Metab. Clin. Exp. pmid:12489060
Ikeda I et al. Mechanisms of phytosterolemia in stroke-prone spontaneously hypertensive and WKY rats. 2001 Metab. Clin. Exp. pmid:11699058
Nguyen TT et al. Cholesterol-lowering effect of stanol ester in a US population of mildly hypercholesterolemic men and women: a randomized controlled trial. 1999 Mayo Clin. Proc. pmid:10593347
Hallikainen M et al. Cholesterol metabolism and serum non-cholesterol sterols: summary of 13 plant stanol ester interventions. 2014 Lipids Health Dis pmid:24766766
Mo S et al. Quantitative analysis of phytosterols in edible oils using APCI liquid chromatography-tandem mass spectrometry. 2013 Lipids pmid:23884629
Forchielli ML et al. The spectrum of plant and animal sterols in different oil-derived intravenous emulsions. 2010 Lipids pmid:20049583
Lupattelli G et al. Cholesterol metabolism differs after statin therapy according to the type of hyperlipemia. 2012 Life Sci. pmid:22554491
Barbosa SP et al. Effects of ezetimibe on markers of synthesis and absorption of cholesterol in high-risk patients with elevated C-reactive protein. 2013 Life Sci. pmid:23507424
Tilvis RS et al. Cholesterol and all-cause mortality in Honolulu. 2001 Lancet pmid:11741659
Nasu K et al. Impact of cholesterol metabolism on coronary plaque vulnerability of target vessels: a combined analysis of virtual histology intravascular ultrasound and optical coherence tomography. 2013 JACC Cardiovasc Interv pmid:23769651
Sharma M et al. Inhibition of sterol biosynthesis reduces tombusvirus replication in yeast and plants. 2010 J. Virol. pmid:20015981
Weingärtner O et al. Plant sterol ester diet supplementation increases serum plant sterols and markers of cholesterol synthesis, but has no effect on total cholesterol levels. 2017 J. Steroid Biochem. Mol. Biol. pmid:27473562